Lyra Therapeutics Inc (LYRA)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

480 ARSENAL STREET WATERTOWN, MA 02472

Lyra Therapeutics, Inc. is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose and throat (ENT) diseases. The company's lead product candidate, LYR-210, is designed to deliver up to six months of continuous anti-inflammatory drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis (CRS) in patients who have not undergone surgery for the disease. Lyra is also developing LYR-220 for CRS patients who have undergone a prior surgery and have persistent disease. Beyond CRS, the company believes its XTreo™ platform, comprised of drug administered through a bioresorbable polymeric matrix, has the potential to address other disease areas by precisely, consistently and locally delivering medicines for sustained periods with a single administration.

Data as of 2021-08-02 09:13:30 -0400
Market Cap83.727 Million Shares Outstanding13.001 Million Avg 30-day Volume46.381 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-0.21 Enterprise Value
Total Cash Current Debt Gross Profit
BETA0.91428 52-week High/Low16.5 / 6.18 Next Earnings Date2021-08-09 Price to Cash FLow (P/CF) -13.3319
Data provided by IEX Cloud
View SEC Filings from LYRA instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 1 1 0.0% 0 (0.0%) 0 (0.0%)
Funds Holding: 51 45 13.33% 16 (0.94%) 15 (0.87%) 6.67%
13F shares: 7.559 Million 8.596 Million -12.06% 5.19 Million 6.506 Million -20.22%
% Ownership 58.384 66.4964 -12.2% 40.0874 50.3299 -20.35%
New Positions: 11 10 10.0% 4 4 0.0%
Increased Positions 14 22 -36.36% 5 6 -16.67%
Closed Positions 4 7 -42.86% 3 1 200.0%
Reduced Positions 14 3 366.67% 5 2 150.0%
Total Calls
Total Puts
PUT/CALL Ratio
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding LYRA (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding LYRA BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

3.5 Thousand total shares from 1 transactions

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

MERRIFIELD C ANN

  • Director
3,500 2021-06-17 2

POUKALOV KONSTANTIN

  • Director
7,250 2021-05-26 1

ALTMAN MICHAEL SETH

  • Director
7,250 2021-05-26 1

SMITH W BRADFORD

  • Director
7,250 2021-05-26 1

ANDERSON EDWARD T

  • Director
7,250 2021-05-26 1

SNYDERMAN NANCY LYNN MD

  • Director
7,250 2021-05-26 4

ELSEY R DON CFO, TREASURER & SECRETARY

  • Officer
0 2021-02-08 1

NOYES CORINNE SEE REMARKS

  • Officer
0 2021-02-08 1

PALASIS MARIA PRESIDENT & CEO

  • Officer
  • Director
0 2021-02-08 1

RICHARD ROBERT E. SVP OF R&D

  • Officer
0 2021-02-08 1

NELSON PAMELA E. SENIOR VP, REGULATORY AFFAIRS

  • Officer
0 2021-02-08 1

LANGER ROBERT

  • Director
15,167 2020-05-05 0

ROBERTS CARMICHAEL

  • 10% Owner
No longer subject to file 2020-05-05 0

WHITESIDES GEORGE M

  • Director
55,064 2020-05-05 0

NBVM GP, LLC

DAMORE RICHARD A

NORTH BRIDGE VENTURE PARTNERS V A LP

NORTH BRIDGE VENTURE PARTNERS V-B LP

NORTH BRIDGE VENTURE PARTNERS VI L P

NORTH BRIDGE VENTURE MANAGEMENT V, L.P.

NORTH BRIDGE VENTURE MANAGEMENT VI, L.P.

  • 10% Owner
4,619,351 2020-05-05 0

POLARIS VENTURE MANAGEMENT CO IV LLC

POLARIS VENTURE PARTNERS ENTREPRENEURS FUND IV LP

POLARIS VENTURE PARTNERS IV LP

  • 10% Owner
322,920 2020-05-05 0

POLARIS VENTURE MANAGEMENT CO. V, L.L.C.

POLARIS VENTURE PARTNERS SPECIAL FOUNDERS' FUND V, L.P.

POLARIS VENTURE PARTNERS V, L.P.

POLARIS VENTURE PARTNERS ENTREPRENEURS' FUND V, L.P.

POLARIS VENTURE PARTNERS FOUNDERS' FUND V, L.P.

MCGUIRE TERRANCE

FLINT JONATHAN A

  • 10% Owner
3,169,298 2020-05-05 0

PERCEPTIVE ADVISORS LLC

PERCEPTIVE LIFE SCIENCES MASTER FUND LTD

PERCEPTIVE LS (A), LLC

EDELMAN JOSEPH

  • Director
  • 10% Owner
4,502,904 2020-05-05 0

SOLEUS PRIVATE EQUITY GP I, LLC

SOLEUS PRIVATE EQUITY FUND I, L.P.

SOLEUS PE GP I, LLC

SOLEUS CAPITAL MASTER FUND, L.P.

SOLEUS CAPITAL, LLC

SOLEUS CAPITAL GROUP, LLC

LEVY GUY

  • 10% Owner
No longer subject to file 2020-05-05 0

EDGERLY-PFLUG LAURA SEE REMARKS

  • Officer
20,046 2020-04-30 0

MOTT RICHARD W

  • 10% Owner
50,462 2020-04-30 0

PERCEPTIVE ADVISORS LLC

EDELMAN JOSEPH

  • Director
  • 10% Owner
14,500 2020-04-30 0

SOLEUS PRIVATE EQUITY GP I, LLC

SOLEUS PRIVATE EQUITY FUND I, L.P.

SOLEUS PE GP I, LLC

LEVY GUY

  • 10% Owner
0 2020-04-30 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

MERRIFIELD C ANN - Director

2021-06-22 16:28:05 -0400 2021-06-17 P 3,500 $8.97 a 3,500 direct 0.0 -4.8578 6.3981 4 -4.8578 6

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
LYRA THERAPEUTICS INC LYRA 2021-08-05 22:15:04 UTC -1.168 1.248 300000
LYRA THERAPEUTICS INC LYRA 2021-08-05 21:45:03 UTC -1.168 1.248 300000
LYRA THERAPEUTICS INC LYRA 2021-08-05 21:15:03 UTC -1.168 1.248 300000
LYRA THERAPEUTICS INC LYRA 2021-08-05 20:45:03 UTC -1.168 1.248 300000
LYRA THERAPEUTICS INC LYRA 2021-08-05 20:15:04 UTC -1.168 1.248 300000
LYRA THERAPEUTICS INC LYRA 2021-08-05 19:45:04 UTC -1.168 1.248 300000
LYRA THERAPEUTICS INC LYRA 2021-08-05 19:15:03 UTC -1.168 1.248 300000
LYRA THERAPEUTICS INC LYRA 2021-08-05 18:45:03 UTC -1.1484 1.2284 300000
LYRA THERAPEUTICS INC LYRA 2021-08-05 18:15:03 UTC -1.1484 1.2284 300000
LYRA THERAPEUTICS INC LYRA 2021-08-05 17:45:03 UTC -1.1484 1.2284 300000
LYRA THERAPEUTICS INC LYRA 2021-08-05 17:15:03 UTC -1.1484 1.2284 300000
LYRA THERAPEUTICS INC LYRA 2021-08-05 16:45:02 UTC -1.1484 1.2284 300000
LYRA THERAPEUTICS INC LYRA 2021-08-05 16:15:03 UTC -1.1484 1.2284 300000
LYRA THERAPEUTICS INC LYRA 2021-08-05 15:45:03 UTC -1.1484 1.2284 300000
LYRA THERAPEUTICS INC LYRA 2021-08-05 15:15:02 UTC -1.1484 1.2284 300000
LYRA THERAPEUTICS INC LYRA 2021-08-05 14:45:02 UTC -1.129 1.209 300000
LYRA THERAPEUTICS INC LYRA 2021-08-05 14:15:04 UTC -1.129 1.209 300000
LYRA THERAPEUTICS INC LYRA 2021-08-05 13:45:04 UTC -1.129 1.209 300000
LYRA THERAPEUTICS INC LYRA 2021-08-05 13:15:03 UTC -1.129 1.209 300000
LYRA THERAPEUTICS INC LYRA 2021-08-05 12:45:03 UTC -1.129 1.209 300000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments